BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 82 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $12 | -99.9% | 46,328 | +985.7% | 0.00% | – |
| Q3 2021 | $14,000 | -54.8% | 4,267 | -46.6% | 0.00% | – |
| Q2 2021 | $31,000 | -68.4% | 7,988 | -68.7% | 0.00% | – |
| Q1 2021 | $98,000 | +151.3% | 25,500 | +193.4% | 0.00% | – |
| Q4 2020 | $39,000 | -82.4% | 8,690 | -33.6% | 0.00% | – |
| Q3 2020 | $221,000 | +34.8% | 13,080 | -10.8% | 0.00% | – |
| Q2 2020 | $164,000 | – | 14,667 | +488800.0% | 0.00% | – |
| Q4 2019 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |